| Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques F Meng, U Gala, H Chauhan Drug development and industrial pharmacy 41 (9), 1401-1415, 2015 | 128 | 2015 |
| Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions UH Gala, DA Miller, RO Williams III Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (1), 188319, 2020 | 94 | 2020 |
| Principles and applications of Raman spectroscopy in pharmaceutical drug discovery and development U Gala, H Chauhan Expert opinion on drug discovery 10 (2), 187-206, 2015 | 75 | 2015 |
| Pharmaceutical applications of eutectic mixtures U Gala, H Pham, H Chauhan J. Dev. Drugs 2 (3), 1-2, 2013 | 57 | 2013 |
| Characterization and comparison of lidocaine-tetracaine and lidocaine-camphor eutectic mixtures based on their crystallization and hydrogen-bonding abilities U Gala, MC Chuong, R Varanasi, H Chauhan Aaps Pharmscitech 16, 528-536, 2015 | 40 | 2015 |
| Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions U Gala, D Miller, RO Williams III Pharmaceutics 12 (4), 357, 2020 | 32 | 2020 |
| Taste Masking Techniques in the Pharmaceutical Industry U Gala, H Chauhan American Pharmaceutical Review 17 (4), 24, 2014 | 18 | 2014 |
| The effect of drug loading on the properties of abiraterone–hydroxypropyl beta cyclodextrin solid dispersions processed by solvent free KinetiSol® technology UH Gala, DA Miller, Y Su, A Spangenberg, ROB Williams III European Journal of Pharmaceutics and Biopharmaceutics 165, 52-65, 2021 | 16 | 2021 |
| Preparation, characterization and dissolution study for curcumin-resveratrol-cyclodextrin amorphous ternary system U Gala Creighton University, 2015 | 6 | 2015 |
| Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof D Miller, U Gala US Patent App. 16/136,413, 2019 | 3 | 2019 |
| Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison SA Thompson, U Gala, DA Davis Jr, S Kucera, D Miller, RO Williams III AAPS PharmSciTech 24 (6), 137, 2023 | 2 | 2023 |
| Inclusion complexes of pharmaceuticals and cyclic oligomers RO Williams III, U Gala, D Miller, A Spangenberg, DJ Ellenberger US Patent App. 17/777,102, 2022 | | 2022 |
| Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof D Miller, U Gala, RO Williams III, A Spangenberg US Patent App. 17/437,144, 2022 | | 2022 |
| Improved prostate cancer therapeutics through KinetiSol® enabled amorphous solid dispersions of Abiraterone UH Gala | | 2019 |
